We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+5.41%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$141M
AUM Growth
+$6.43M
Cap. Flow
+$9.56M
Cap. Flow %
6.78%
Top 10 Hldgs %
55.72%
Holding
161
New
36
Increased
33
Reduced
7
Closed
45

Top Buys

Rank Stock Value
1
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
+$8.56M
2
INFO
IHS Markit Ltd. Common Shares
INFO
+$3.47M
3
NUAN
Nuance Communications, Inc.
NUAN
+$3.42M
4
CPARU
Catalyst Partners Acquisition Corp. Unit
CPARU
+$2.01M
5
ATHM icon
Autohome
ATHM
+$1.32M

Top Sells

Rank Stock Value
1
IPHI
INPHI CORPORATION
IPHI
+$3.84M
2
RP
RealPage, Inc.
RP
+$3.37M
3
INDA icon
iShares MSCI India ETF
INDA
+$2.29M
4
GNW icon
Genworth Financial
GNW
+$1.92M
5
BABA icon
Alibaba
BABA
+$1.79M

Sector Composition

Rank Sector Weight
1 Technology 32.85%
2 Healthcare 32.22%
3 Financials 6.7%
4 Communication Services 6.68%
5 Consumer Discretionary 4.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRTX
51
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$796K 0.56%
4,926
+660
+15% +$106K
RVMD icon
52
Revolution Medicines
RVMD
$44.4B
$795K 0.56%
25,038
+8,046
+47% +$281K
NBIX icon
53
Neurocrine Biosciences
NBIX
$16.8B
$792K 0.56%
+8,140
New +$780K
TVTX icon
54
Travere Therapeutics
TVTX
$5.74B
$781K 0.55%
53,498
+28,876
+117% +$570K
NRIX icon
55
Nurix Therapeutics
NRIX
$2.69B
$779K 0.55%
29,380
+10,158
+53% +$298K
KNTE
56
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$777K 0.55%
+33,391
New +$850K
XLRN
57
DELISTED
Acceleron Pharma
XLRN
$775K 0.55%
+6,177
New +$779K
BPMC
58
DELISTED
Blueprint Medicines
BPMC
$774K 0.55%
+8,805
New +$807K
ONC
59
BeOne Medicines Ltd
ONC
$40.6B
$766K 0.54%
2,231
– –
XENE icon
60
Xenon Pharmaceuticals
XENE
$6.21B
$763K 0.54%
+40,959
New +$755K
ISEE
61
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$751K 0.53%
118,965
-22,090
-16% -$143K
FMTX
62
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$714K 0.51%
28,685
+8,055
+39% +$216K
ACRS icon
63
Aclaris Therapeutics
ACRS
$867M
$697K 0.49%
+39,675
New +$901K
EPIX
64
DELISTED
ESSA Pharma
EPIX
$686K 0.49%
+24,026
New +$698K
MGNX icon
65
MacroGenics
MGNX
$259M
$674K 0.48%
25,104
-13,118
-34% -$384K
NTLA icon
66
Intellia Therapeutics
NTLA
$1.68B
$597K 0.42%
3,685
– –
YUMC icon
67
Yum China
YUMC
$16.5B
$588K 0.42%
8,878
-8,221
-48% -$524K
EWTX icon
68
Edgewise Therapeutics
EWTX
$4.84B
$586K 0.42%
+27,467
New +$751K
CRIS icon
69
Curis
CRIS
$7.13M
$467K 0.33%
145
-39
-21% -$176K
EVC icon
70
Entravision Communication
EVC
$1.08B
$269K 0.19%
40,325
+10,379
+35% +$46.9K
BCRX icon
71
BioCryst Pharmaceuticals
BCRX
$2.51B
$242K 0.17%
15,316
– –
IDT icon
72
IDT Corp
IDT
$1.61B
$242K 0.17%
+6,549
New +$186K
TRUE
73
DELISTED
TrueCar
TRUE
$234K 0.17%
41,284
+18,884
+84% +$95.1K
QNST icon
74
QuinStreet
QNST
$1.26B
$229K 0.16%
+12,301
New +$233K
FLNA
75
Filana Therapeutics
FLNA
$48.2M
$212K 0.15%
+2,488
New +$133K
1 2
3
4 5

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
VIA
Virtus Investment Advisers Hartford, Connecticut $363M AUM 34.89% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $361M AUM 134.26% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

HighVista Strategies's Q2 2021 Portfolio in Review

As of Q2 2021, HighVista Strategies held 161 positions worth $141M, up 4.8% from $135M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

HighVista Strategies deployed $9.56M of net new capital in Q2 2021, opening 36 new positions and adding to 33 existing holdings. Its largest new stake was IHS Markit Ltd. Common Shares: 32,743 shares worth $3.69M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Alibaba, an estimated $1.79M trimmed.

  • HighVista Strategies's largest Q2 2021 buy was IHS Markit Ltd. Common Shares: 32,743 shares worth $3.69M.
  • HighVista Strategies added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, an estimated $8.56M increase.
  • HighVista Strategies's biggest Q2 2021 reduction was Alibaba, cutting an estimated $1.79M.
  • HighVista Strategies fully exited INPHI CORPORATION in Q2 2021, selling an estimated $3.84M.
  • HighVista Strategies's ten largest holdings make up 56% of its $141M portfolio in Q2 2021.
  • HighVista Strategies opened 36 new positions and closed 45 in Q2 2021.
  • HighVista Strategies's portfolio value rose 4.8% quarter-over-quarter to $141M.

Based on HighVista Strategies's 13F filing for Q2 2021, filed 16 Aug 2021.